Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Breast Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

October 21, 2021

Primary Completion Date

October 31, 2039

Study Completion Date

October 31, 2039

Conditions
Breast CancerCardiotoxicityDrug-Related Side Effects and Adverse ReactionsCardiovascular Diseases
Interventions
OTHER

Social Determinants of Health

The study will perform detailed phenotyping of Social Determinants of Health using the National Institute of Minority Health and Health Disparities PhenX SDOH toolkit at baseline.

Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

American Heart Association

OTHER

lead

Abramson Cancer Center at Penn Medicine

OTHER